DOCSLIB.ORG

Review Role of Thymidine in Biochemical Modulation: a Review Peter J

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Review Role of Thymidine in Biochemical Modulation: a Review Peter J [CANCER RESEARCH 47, 3911-3919, August 1, 1987] Review Role of Thymidine in Biochemical Modulation: A Review Peter J. O'Dwyer,1 Susan A. King, Daniel F. Hoth, and Brian 1,e>land-Jones Investigational Drug Branch, Cancer Therapy Evaluation Program, Division of Cancer Treatment, National Cancer Institute, Bethesda, Maryland 20892 {P. O., S. A. K., D. F. H., B. L-J.J, and The Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111 [P. OJ Abstract effects on the pathways of precursor synthesis (9), and the effects of their perturbation on DNA integrity and replication The role of thymidine in the treatment of cancer has been under clinical investigation for nearly a decade. C'Unirai trials have demonstrated that (10-13). Administration of exogenous dThd expands the intra- cellular dTTP pool through the salvage pathway of deoxynu- it lacks antitumor activity in its own right. In this review, the mechanism of action and rationale for the use of thymidine as a biochemical modu cleotide biosynthesis (14). The major effect of elevated dTTP lator of standard agents such as 5-fluorouracil, l-/3-r>arabinofuranosyl- levels is believed to be inhibition of ribonucleotide reducíase cytosine, and methotrexate are summarized. With this background, the (IS). Cytotoxicity has been associated with the consequent clinical trials which have been conducted with thymidine, either alone or depletion of dCTP (16, 17); in most cell lines the cytotoxicity in combination, are described. We suggest a number of further studies of can be reversed by replenishing dCTP pools (18,19). Addition the role of thymidine in the biochemical modulation of antimetabolites. ally, elevated levels of ribonucleotide reductase have been as sociated with resistance to dThd-induced cytotoxicity (20). Introduction However, Akman et al. (21) have shown that dCTP administra tion does not universally reverse the effects of dThd, which The naturally occurring nucleoside thymidine has been used suggests that this effect alone may not explain the cytotoxicity for decades to synchronize cells growing in vitro in S-phase (1). to all cell lines. Observations of enhanced sensitivity to DNA- It was introduced into clinical trials in 1978 based on evidence damaging agents (22, 23) and enhanced mutagenesis (24) fol that prolonged exposure to dThd2was cytotoxic to cells in vitro, lowing elevation of dTTP pools support an additional action and that its administration to nude mice bearing human tumor on preformed DNA or its normal repair. xenografts yielded tumor regressions (2, 3). Numerous preclin- The regulation by dTTP of key enzymes of the pyrimidine- ical studies have shown that dThd can modulate the activity of and purine-synthetic pathways, while not primarily responsible active cytotoxic drugs in a synergistic fashion in vitro and in for cytotoxicity, has important implications for the therapeutic vivo. The major goal of clinical studies with dThd has been to use of dThd in combination regimens with other antimetabo replicate this syngergistic interaction in human cancer. Many lites. Alterations in enzyme activity may also play a role in of these studies have incorporated detailed biochemical analysis resistance to the effects of dThd. High dTTP levelsinhibit dThd of the modulation by dThd of antimetabolites such as FUra, kinase and deoxycytidylate deaminase directly and activate ara-C, and MTX. In most cases, however, it is not clear that deoxycytidine kinase (25-27). The ability to maintain high the design of the regimen used in humans replicates that which levels of dTTP depends on the phosphorylases responsible for yields maximal synergy in animals, and no combination has the degradation of dTTP and dThd; differential sensitivity of been subjected to a controlled clinical trial to demonstrate the malignant T-lymphocytes and normal B-lymphocytes has been efficacyof the modulation. dThd has been the subject of several ascribed to differences in phosphorylase activity (28). Hence, excellent reviews (4-6). In this paper, we review the rationale while the major effects of exogenous dThd appear to be exerted for the development of regimens which incorporate dThd in at the level of ribonucleotide reductase, actions at other sites clinical trials, evaluate them from the perspective of their bio (to be described) may determine its synergistic interaction with chemical and pharmacological end points, and indicate the antimetabolites such as ara-C, S-azacytidine, and FUra. clinical studies needed to define the role of dThd used in this A further effect of dThd which may be of relevance to setting. antimetabolite combination is the cytokinetic synchronization of cells in S phase (29,30). From the studies of Kufe and Major Mechanism of Action (31), using ara-C alone, and Ross et al. (32), using deoxygua- nosine as a modulator of ara-C, it would seem that biochemical Deoxynucleoside triphosphate pools in mammalian cells are rather than cytokinetic effects correlate better with cytotoxicity. less than one-tenth the size of corresponding ribonucleoside However, the impetus for the evaluation of dThd as an antitu- triphosphate pools and are sufficient to supply the DNA repli mor agent was provided by its known cytokinetic actions. Lee cation fork with precursors for only 30 s to 5 min (7). Their et al. (2) first demonstrated that continued exposure of cells to importance in the control of DNA synthesis is evidenced by dThd for periods greater than their doubling time resulted in their tight control relative to the cell cycle (8), their regulatory cell death. They later showed that dThd is cytotoxic to human Received 4/3/86; revised 2/26/87; accepted 4/16/87. tumor xenografts in mice, with apparent selectivity for tumor The costs of publication of this article were defrayed in part by the payment over normal cells (3). Negative results were obtained in LI210, of page charges. This article must therefore be hereby marked advertisement in Lewis lung, colon 26, and colon 38, although dThd doses were accordance with 18 U.S.C. Section 1734 solely to indicate this fact. 1To whom requests for reprints should be addressed, at Department of Medical lower than in previous studies (33); however, malignant lym Oncology, Fox Chase Cancer Center, Centra] and Shelmire Avenues, Philadel phocytes appeared to be markedly sensitive (28). These data phia, PA 19111. 2The abbreviations used are; dThd, thymidine; FUra, S-fluorouracil; ara-C, 1- justified initial clinical testing of dThd as an antitumor drug. 0-D-arabinofuranosylcytosine; MTX, methotrexate; CSF, cerebrospinal fluid; Is. Plasma levels of dThd in normal subjects and solid tumor thymidylate synthetase; AMI. acute nonlymphocytic leukemia; I ill Ml'. 5- patients exhibit marked variation over a range from <4 x 10~8 fluorodeoxyuridine 5'-monophosphate; FdUrd, 5-fluorodeoxyuridine; FUTP, 5- to 8.7 x IO"7 M (34). The level required for cytotoxicity is IInon inrid¡notriphosphate; PALA, JV-phosphonacetyl-L-aspartate; ara-CTP, 1-/3- D-arabinofuranosylcytosine triphosphate. several orders of magnitude higher although this varies with 3911 Downloaded from cancerres.aacrjournals.org on September 30, 2021. © 1987 American Association for Cancer Research. ROLE OF THYMIDINE IN BIOCHEMICAL MODULATION the cell line studied, from as low as 6.2 x 10~5 M for LSI78Y of magnitude increase in plasma levels for a single order of lymphoblasts (35) to 1 x 10~2 M for HL-60 (21). In general, magnitude dose increase is accounted for by the prolongation millimolar levels are needed. Such levels expand dTTP pools of the half-life to about 100 min (47-49). Renal clearance at up to 4000% of control (18) but reduce dCTP only to 40 to these levels represents some 50% of total plasma clearance, 60% of control (18, 36). Although this modest depression of which is reduced to 95-266 ml/min/m2 (47, 48). These data dCTP levels has been thought to be insufficient to support a reflect saturation of the metabolic processes which catabolize cytotoxic mechanism involving ribonucleotide reducíase(36), dThd efficiently at low doses and are consistent with the earlier reversal studies show that low levels («3/¿M)ofdeoxycytidine data of Ensminger and Frei (52) in humans which indicated partially reverse dThd-induced growth inhibition without in that hepatic extraction of dThd was saturable at doses between creasing dCTP pools, while higher levels (>8 ^M) restore both 16 and 32 g/m2/day and those of Covey and Straw (44) in the dCTP pools and normal growth in parallel (18). Endogenous dog. However, calculations based on liver plasma flow indicate deoxycytidine may also prevent the expression of dThd cyto- that the liver cannot be the major site of dThd metabolism; the toxicity /// rmi against 11210 cells against which it is active in presence of dThd phosphorylase activity in plasma, kidney, vitro (37). Zaharko and Covey (38) have shown that the effects spleen, and intestinal mucosa suggests that dThd is widely of dThd on deoxycytidine metabolism are dependent on the catabolized in the body (44, 47). The major product of this model used; a selective advantage for tumor over normal tissue process, thymine, is present at plasma levels which are of the effects of dThd could not be demonstrated in the mouse. How order of those of dThd but which decay with a half-life over 3- ever, endogenous deoxycytidine levels, which may be as high as fold longer (47). The renal contribution to thymine clearance 2 x IO"5 M in rodents (39), are usually less than 1 x 10~6 M in is some 13-18% of total body clearance (47). humans (39, 40). Therefore, humans may be more susceptible Renal handling of dThd also varies in a dose-dependent to its cytotoxic effects. manner. At micromolar levels, urinary clearance of dThd ex On the basis of its activity against the human tumor xeno- ceeds creatinine clearance by a factor of 4 (42), while at milli grafts (3), dThd was introduced into clinical trials by the Na molar levels this factor is reduced to 1.65 (47).
Load more

Recommended publications
  • Peritoneal Cells
    Immunology 1976 30 741 Two distinct lymphocyte-stimulating soluble factors (LAF) released from murine peritoneal cells I. THE CELLULAR SOURCE AND THE EFFECT OF cGMP ON THEIR RELEASE T. DIA MANTSTEIN & A. UL MER Immunological Research Unit, Klinikum Steglitz Freie Universitdt, Berlin, Germany Received 26 September 1975; acceptedfor publication 30 October 1975 Summary. Culture fluids of murine peritoneal cells similar lymphocyte (predominantly thymocyte)- contain two distinct, non-dialysable principles activating factor(LAF) and lymphocyteproliferation- (LAF) with thymocyte proliferation-stimulating inhibiting factor (LIF) can be obtained by incubat- properties. One of them is elaborated from phago- ing normal peritoneal mouse cells (rich in non- cytic cells (presumably macrophages), the other is stimulated macrophages) in the presence of cyclic- released by non-phagocytic cells (lymphocytes). 3',5'-guanosine monophosphate (cGMP). This paper cGMP added exogenously stimulates the production reports in detail on this phenomenon with respect and/or release of LAF from phagocytic cells, but not to the specificity of cGMP as an inducer for LAF from non-phagocytic cells. The phagocytic cells (but release and the identity of the cells releasing LAF in not the lymphocytes) require intact RNA and pro- presence and absence ofcGMP. tein synthesis for LAF release. The action of LAF differs from those of cGMP itself by being non- dialysable, and unable to prevent the inhibitory MATERIALS AND METHODS action of cAMP on mitogen-stimulated lymphocyte proliferation.
    [Show full text]
  • Alternative Biochemistries for Alien Life: Basic Concepts and Requirements for the Design of a Robust Biocontainment System in Genetic Isolation
    G C A T T A C G G C A T genes Review Alternative Biochemistries for Alien Life: Basic Concepts and Requirements for the Design of a Robust Biocontainment System in Genetic Isolation Christian Diwo 1 and Nediljko Budisa 1,2,* 1 Institut für Chemie, Technische Universität Berlin Müller-Breslau-Straße 10, 10623 Berlin, Germany; [email protected] 2 Department of Chemistry, University of Manitoba, 144 Dysart Rd, 360 Parker Building, Winnipeg, MB R3T 2N2, Canada * Correspondence: [email protected] or [email protected]; Tel.: +49-30-314-28821 or +1-204-474-9178 Received: 27 November 2018; Accepted: 21 December 2018; Published: 28 December 2018 Abstract: The universal genetic code, which is the foundation of cellular organization for almost all organisms, has fostered the exchange of genetic information from very different paths of evolution. The result of this communication network of potentially beneficial traits can be observed as modern biodiversity. Today, the genetic modification techniques of synthetic biology allow for the design of specialized organisms and their employment as tools, creating an artificial biodiversity based on the same universal genetic code. As there is no natural barrier towards the proliferation of genetic information which confers an advantage for a certain species, the naturally evolved genetic pool could be irreversibly altered if modified genetic information is exchanged. We argue that an alien genetic code which is incompatible with nature is likely to assure the inhibition of all mechanisms of genetic information transfer in an open environment. The two conceivable routes to synthetic life are either de novo cellular design or the successive alienation of a complex biological organism through laboratory evolution.
    [Show full text]
  • Cytotoxic and Biochemical Effects of Thymidine and 3-Deazauridine on Human Tumor Cells1
    [CANCER RESEARCH 44, 2534-2539. June 1984] Cytotoxic and Biochemical Effects of Thymidine and 3-Deazauridine on Human Tumor Cells1 Arnold Lockshin, John T. Mendoza, Beppino C. Giovanella,2 and John S. Stehlin, Jr. St. Joseph Hospital Laboratory for Cancer Research, Houston, Texas 77002 ABSTRACT cells, thymidine-resistant human malignant B-cells have much lower ratios of these activities (6, 19). The cause of thymidine- Cytotoxicity and perturbations of the deoxyribonucleoside tri- induced inhibition of DNA synthesis in mammalian cells has been phosphate pools caused by thymidine were studied in thymidine- ascribed to depletion of the intracellular dCTP pool brought about sensitive and -resistant human tumor cells. Incubation with 1 mw by allosteric effects of dTTP on ribonucleotide reducíase(2, 33, thymidine reduced cell viability by more than 90% in the three 36). Other investigators have concluded that the decrease in the sensitive cell lines (two melanomas and one adrenal carcinoma) dCTP pool is too small to account for growth inhibition of L1210 and reduced the growth rate without decreasing the viability of murine leukemia cells (14) and that high levels of dTTP (and/or resistant LO melanoma cells. Thymidine (1 HIM)greatly increased other dNTPs3) interact with a regulatory protein for DNA polym- the ratio of the deoxythymidine 5'-triphosphate to deoxycytidine 5'-triphosphate pools in the sensitive cells compared to LO cells erase (37). Yet another interpretation is that imbalance of the pyrimidine dNTP pools brought about by supranormal levels of and also caused larger relative increases in the pool sizes of deoxyguanosine 5'-triphosphate and deoxyadenosine 5'-tri- exogenous thymidine causes misincorporation of bases into DNA, which leads to mutagenicity and cytotoxicity (4).
    [Show full text]
  • Alteration of Nucleoside Transport of Chinese Hamster Cells By
    Proc. Nat. Acad. Sci. USA Vol. 69, No. 12, pp. 3542-3546, December 1972 Alteration of Nucleoside Transport of Chinese Hamster Cells by Dibutyryl Adenosine 3':5'-Cyclic Monophosphate (thymidine and uridine uptake/thymidine kinase/DNA and RNA synthesis) PETER V. HAUSCHKA, LEIGHTON P. EVERHART, AND ROBERT W. RUBIN Department of Molecular, Cellular and Developmental Biology, University of Colorado, Boulder, Colo. 80302 Communicated by Keith R. Porter, September 21, 1972 ABSTRACT Cultured Chinese hamster ovary cells served alterations that they induce in plasma membrane showed no significant change in generation time or frac- tion in the S-phase in the presence of 1 mM N6,02'-di- properties. Bu2cAMP causes a large decrease in the agglutin- butyryl adenosine 3': 5'-cyclic monophosphate. Growth ability of mouse fibroblasts by wheat-germ agglutinin (8), continued for at least two generations after expression of and increased adhesion to plastic surfaces (10). We studied the the morphological transformation induced by this cyclic effect of Bu2cAMP on DNA synthesis in CHO cells; our AMP analog. Despite identical growth rates, apparent attention soon focussed on metabolite transport, because it rates of DNA and RNA synthesis (incorporation of [3Hl- thymidine or [IHluridine) were reduced up to 15-fold in appeared that this process was most severely affected by log phase by 1 mM cyclic nucleotide. PIHiDeoxycytidine Bu2cAMP. incorporation was much less sensitive to dibutyryl cyclic AMP. Uptake studies with [,;H]thymidine demonstrated MATERIALS AND METHODS an inhibition of transport rate dependent on the concen- Chinese hamster ovary cells (line CHO) were originally ob- tration of dibutyryl cyclic AMP in the growth medium.
    [Show full text]
  • A Previously Undescribed Pathway for Pyrimidine Catabolism
    A previously undescribed pathway for pyrimidine catabolism Kevin D. Loh*†, Prasad Gyaneshwar*‡, Eirene Markenscoff Papadimitriou*§, Rebecca Fong*, Kwang-Seo Kim*, Rebecca Parales¶, Zhongrui Zhouʈ, William Inwood*, and Sydney Kustu*,** *Department of Plant and Microbial Biology, 111 Koshland Hall, University of California, Berkeley, CA 94720-3102; ¶Section of Microbiology, 1 Shields Avenue, University of California, Davis, CA 95616; and ʈCollege of Chemistry, 8 Lewis Hall, University of California, Berkeley, CA 94720-1460 Contributed by Sydney Kustu, January 19, 2006 The b1012 operon of Escherichia coli K-12, which is composed of tive N sources. Here we present evidence that the b1012 operon seven unidentified ORFs, is one of the most highly expressed codes for proteins that constitute a previously undescribed operons under control of nitrogen regulatory protein C. Examina- pathway for pyrimidine degradation and thereby confirm the tion of strains with lesions in this operon on Biolog Phenotype view of Simaga and Kos (8, 9) that E. coli K-12 does not use either MicroArray (PM3) plates and subsequent growth tests indicated of the known pathways. that they failed to use uridine or uracil as the sole nitrogen source and that the parental strain could use them at room temperature Results but not at 37°C. A strain carrying an ntrB(Con) mutation, which Behavior on Biolog Phenotype MicroArray Plates. We tested our elevates transcription of genes under nitrogen regulatory protein parental strain NCM3722 and strains with mini Tn5 insertions in C control, could also grow on thymidine as the sole nitrogen several genes of the b1012 operon on Biolog (Hayward, CA) source, whereas strains with lesions in the b1012 operon could not.
    [Show full text]
  • Effects of Uridine and Thymidine on the Degradation of 5-Fluorouracil, Uracil, and Thymine by Rat Liver Dihydropyrimidine Dehydrogenase1
    [CANCER RESEARCH 45, 5553-5556, November 1985] Effects of Uridine and Thymidine on the Degradation of 5-Fluorouracil, Uracil, and Thymine by Rat Liver Dihydropyrimidine Dehydrogenase1 Mendel Tuchman,2 Margaret L. R. Ramnaraine, and Robert F. O'Dea Divisions of Metabolism and Clinical Pharmacology, Departments ol Pediatrics and Pharmacology, University ot Minnesota, Minneapolis, Minnesota 55455 ABSTRACT growing or malignant cells and that the activity is diminished in livers of newborn animals (5,18). The kinetic properties and control mechanisms of 5-fluorouracil We have recently described two siblings from a family who (5-FU), uracil, and thymine degradation by rat liver dihydropy- excreted high levels of uracil and thymine in their urine. One rimidine dehydrogenase were studied in vitro. The calculated sibling developed severe toxicity when treated with 5-FU for Michaelis constant (K,,,)for 5-FU was 3.49 ±0.41 (SE) /IM, similar breast cancer. We proposed a genetic defect in DPD as the to those for uracil (2.26 ±0.28 ¿¿M)andfor thymine (2.23 ±0.34 etiology of the clinical and biochemical findings (17). The inves /»M).However,the reduction of 5-FU appears to be most sensitive tigation of this family prompted further studies of 5-FU degra to the inhibitory effects of increased substrate concentration. dation in vitro and an examination of possible mechanisms which The specific activities of dihydropyrimidine dehydrogenase (nmol/ could modulate the enzymatic reduction of 5-FU by DPD. min/mg of protein) for 5-FU, uracil, and thymine were 0.82,0.68, and 0.56, respectively.
    [Show full text]
  • Nucleotide Metabolism Pathway: the Achilles' Heel for Bacterial Pathogens
    REVIEW ARTICLES Nucleotide metabolism pathway: the achilles’ heel for bacterial pathogens Sujata Kumari1,2,* and Prajna Tripathi1,3 1National Institute of Immunology, New Delhi 110 067, India 2Present address: Department of Zoology, Magadh Mahila College, Patna University, Patna 800 001, India 3Present address: Institute of Molecular Medicine, Jamia Hamdard, New Delhi 110 062, India de novo pathway, the nucleotides are synthesized from Pathogens exploit their host to extract nutrients for their survival. They occupy a diverse range of host simple precursor molecules. In the salvage pathway, the niches during infection which offer variable nutrients preformed nucleobases or nucleosides which are present accessibility. To cause a successful infection a patho- in the cell or transported from external environmental gen must be able to acquire these nutrients from the milieu to the cell are utilized to form nucleotides. host as well as be able to synthesize the nutrients on its own, if required. Nucleotides are the essential me- tabolite for a pathogen and also affect the pathophysi- Purine biosynthesis pathway ology of infection. This article focuses on the role of nucleotide metabolism of pathogens during infection The purine biosynthesis pathway is universally conserved in a host. Nucleotide metabolism and disease pathoge- in living organisms (Figure 1). As an example, we here nesis are closely related in various pathogens. Nucleo- present the pathway derived from well-studied Gram- tides, purines and pyrimidines, are biosynthesized by positive bacteria Lactococcus lactis. In the de novo the de novo and salvage pathways. Whether the patho- pathway the purine nucleotides are synthesized from sim- gen will employ the de novo or salvage pathway dur- ple molecules such as phosphoribosyl pyrophosphate ing infection is dependent on various factors, like (PRPP), amino acids, CO2 and NH3 by a series of enzy- availability of nucleotides, energy condition and pres- matic reactions.
    [Show full text]
  • Cellular Sources of Thymidine Nucleotides: Studies for PET
    Cellular Sources of Thymidine Nucleotides: Studies for PET Anthony F. Shields, Dean V. Coonrod, Robert C. Quackenbush, and John J. Crowley Fred Hutchinson Cancer Research Center, and Departments of Medicine and Biostatistics, University of Washington, Seattle, Washington The relative utilization of endogenously synthesized thymidine nucleotides and exogenously supplied thymidine analog was compared in a number of mammalian cell lines, tissues, and tumors. To measure the relative utilization, cells were incubated in tissue culture media containing the thymidine analog [3H]-5-bromo-2'-deoxyuridine (BUDR). After extraction of the DNA, the degree of substitution of the thymidine by BUDR was determined by density gradient centrifugation. All the cell lines and tissues tested utilized both exogenous BUDR and endogenous thymidine sources to a similar extent. The relative utilization of the exogenous pathway could be manipulated by varying the exogenous concentration of BUDR. Our results demonstrate that one can predict the relative utilization of these two pathways and can calculate the effective specific activity of the intracellular thymidine nucleotide pool. Such information is needed in interpreting "C-labeled thymidine uptake as measured by positron emission tomography. J NucíMed 28:1435-1440,1987 WT Teire are interested in the development of carbon-11- exogenous and endogenous sources mix in a single ("C) labeled thymidine as an imaging agent for positron intracellular pool (5-7). We sought to overcome some emission tomography (PET), but the interpretation of of the limitations of these previous studies by directly such images requires a detailed knowledge of the bio and quantitatively measuring the relative activities of chemistry and kinetics of thymidine uptake these two pathways, and to examine primary tissues (1-3).
    [Show full text]
  • Consequences of Methotrexate Inhibition of Purine Biosynthesis in L5178Y Cells'
    [CANCER RESEARCH 35, 1427-1432,June 1975] Consequences of Methotrexate Inhibition of Purine Biosynthesis in L5178Y Cells' William M. Hryniuk2 Larry W. Brox,3J. Frank Henderson, and Taiki Tamaoki DepartmentofMedicine, University ofManitoba,and TheManitoba Institute ofCellBiology, Winnipeg,Manitoba [W. M. H.J and CancerResearch Unit (McEachern Laboratory), and DepartmentofBiochemistry, University ofAlberta, Edmonton,Alberta T6G 2E1 [L. W. B.,J. F. H., T. T.J,Canada SUMMARY recently been shown that the cytotoxicity of methotrexate against cultured mouse lymphoma L5178Y cells is in part Addition of 1 @Mmethotrexate to cultures of L5178Y attributable to a “purineless―state(6, 7). Thus, hypoxan cells results in an initial inhibition ofthymidine, uridine, and thine partially prevented the methotrexate-induced inhibi leucine incorporation into acid-insoluble material followed, tion of thymidine, uridine, and leucine incorporation into after about 10 hr. by a partial recovery in the extent of macromolecules and also delayed the loss ofcell viability, as incorporation of these precursors. Acid-soluble adenosine measured by cloning experiments. These studies also triphosphate and guanosine triphosphate concentrations are showed that, during incubation of L5178Y cells with greatly reduced initially, but guanosine triphosphate con methotrexate in the absence of hypoxanthine, incorporation centrations appear to recover partially by 10 hr. Acid of thymidine into DNA was first inhibited but later partially soluble uridine triphosphate and cytidine
    [Show full text]
  • The Influence of Intracellular Levels of Cyclic Nucleotides on Cell Proliferation and the Induction of Antibody Synthesis*, $
    THE INFLUENCE OF INTRACELLULAR LEVELS OF CYCLIC NUCLEOTIDES ON CELL PROLIFERATION AND THE INDUCTION OF ANTIBODY SYNTHESIS*, $ BY JAMES WATSON (From The Salk Institute for Biological Studies, San Diego, California 92112) Precursor antibody-forming cells (AFC)' are those bone marrow-derived (B) lymphocytes that are committed to follow several terminal pathways . Precursor cells can respond to antigen by proliferation and maturation to AFC (induction), or by inactivation in that cells are rendered noninducible (paralysis) . Haptens coupled to immunogenic carriers elicit hapten-specific immune responses in animals, but haptens on nonimmunogenic carriers do not (1-7) . Haptens on nonimmunogenic carriers are not inert because they induce a hapten-specific unresponsiveness which is due to a direct inactivation of the precursors of AFC, and not to an indirect suppressive event (1, 4-8) . Since haptens on nonimmunogenic carriers inactivate precursor cells in the absence of thymus-derived (T) cells, the interaction between haptens and immunoglobulin receptors on the surface of precursor cells is sufficient to initiate the intracellular events that constitute the paralytic pathway. A number of haptens on nonimmunogenic carriers have been shown to elicit hapten-specific immune responses when a T-cell signal acting on precursor cells is provided by allogeneic lymphoid cells (4, 6, 8) or by bacterial lipopolysaccharides (LPS) (9, 10), implying that the T-cell signal diverts those cells binding hapten from a paralytic to an inductive pathway . These experiments also suggest that the inductive stimulus is delivered to precursor cells via two membrane-mediated events : the first by the binding of haptenic determinants to surface immunoglobulin receptors and the second by a T-cell signal acting on precursor cells.
    [Show full text]
  • Dynamics of Pyrimidine Deoxynucleoside Triphosphate
    Proc. Nati Acad. Sci. USA Vol. 80, pp. 1347-1351, March 1983 Cell Biology Dynamics of pyrimidine deoxynucleoside triphosphate pools in relationship to DNA synthesis in 3T6 mouse fibroblasts (nucleoside incorporation/compartmentation/amethopterin block) BjORN NICANDER AND PETER REICHARD Medical Nobel Institute, Department of Biochemistry I, Karolinska Institutet, Box 60400, S-104 01 Stockholm, Sweden Contributed by Peter A. Reichard, November 18, 1982 ABSTRACT The 3H-labeled nucleosides cytidine, deoxycyti- tivity into DNA to this value (1, 2). Such a procedure becomes dine, and thymidine are rapidly incorporated into DNA via dCTP imperative when one wishes to distinguish between effects of or dTTP pools. Between 30 and 60 minafter addition of tracer different manipulations-e. g., pharmacological interference- amounts ofa labeled nucleoside to the medium ofrapidly growing on precursor synthesis and DNA replication. Knowing the spe- 3T6 cells, dNTPpools attained a constant specific activity resulting cific activity of a dNTP under steady-state conditions may in from a steady-state equilibrium between incorporation of nucleo- addition permit determination of absolute rather than relative side, de novo synthesis, and linear incorporation of isotope into rates of DNA synthesis. DNA. Removal oflabeled deoxycytidine or thymidine depleted the The of dNTP pools ofisotope within a few minutes and incorporation into possibility compartmentation of dNTP pools poses DNA stopped. When de novo synthesis ofdTTP was blocked with additionalicomplications (3). Fractionation ofcells in nonaque- amethopterin, the intracellular dTTP pool rapidly reached the ous media led to -the suggestion of separate cytoplasmic and. specific activity of thymidine of' the medium and isotope-incor- nuclear dNTP pools in Chinese hamster ovary cells (4).
    [Show full text]
  • Guanosine-Based Nucleotides, the Sons of a Lesser God in the Purinergic Signal Scenario of Excitable Tissues
    International Journal of Molecular Sciences Review Guanosine-Based Nucleotides, the Sons of a Lesser God in the Purinergic Signal Scenario of Excitable Tissues 1,2, 2,3, 1,2 1,2, Rosa Mancinelli y, Giorgio Fanò-Illic y, Tiziana Pietrangelo and Stefania Fulle * 1 Department of Neuroscience Imaging and Clinical Sciences, University “G. d’Annunzio” of Chieti-Pescara, 66100 Chieti, Italy; [email protected] (R.M.); [email protected] (T.P.) 2 Interuniversity Institute of Miology (IIM), 66100 Chieti, Italy; [email protected] 3 Libera Università di Alcatraz, Santa Cristina di Gubbio, 06024 Gubbio, Italy * Correspondence: [email protected] Both authors contributed equally to this work. y Received: 30 January 2020; Accepted: 25 February 2020; Published: 26 February 2020 Abstract: Purines are nitrogen compounds consisting mainly of a nitrogen base of adenine (ABP) or guanine (GBP) and their derivatives: nucleosides (nitrogen bases plus ribose) and nucleotides (nitrogen bases plus ribose and phosphate). These compounds are very common in nature, especially in a phosphorylated form. There is increasing evidence that purines are involved in the development of different organs such as the heart, skeletal muscle and brain. When brain development is complete, some purinergic mechanisms may be silenced, but may be reactivated in the adult brain/muscle, suggesting a role for purines in regeneration and self-repair. Thus, it is possible that guanosine-50-triphosphate (GTP) also acts as regulator during the adult phase. However, regarding GBP, no specific receptor has been cloned for GTP or its metabolites, although specific binding sites with distinct GTP affinity characteristics have been found in both muscle and neural cell lines.
    [Show full text]